Trials / Withdrawn
WithdrawnNCT01977339
Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty
A Randomized, Double-Blinded, Control Trial to Evaluate the Efficacy of Single Injection Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia in Subjects Undergoing Unilateral Total Knee Arthroplasty
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- St. Luke's-Roosevelt Hospital Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the quality and duration of pain relief after a total knee replacement provided by a single shot of standard bupivacaine versus a single shot of liposomal bupivacaine, at the site of the femoral nerve. It is hypothesized that the liposomal bupivacaine formulation will provide more effective pain relief than standard bupivacaine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liposome Bupivacaine | 10 cc of 266 mg liposome bupivacaine with 10 cc of Normal Saline |
| DRUG | Bupivacaine | 20 cc of 0.25% bupivacaine |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2013-11-06
- Last updated
- 2017-04-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01977339. Inclusion in this directory is not an endorsement.